Skip to main contentSkip to main content
Updating results


  • Updated

MONDAY, Nov. 28, 2022 (HealthDay News) -- Sotrovimab is effective compared with molnupiravir for patients at high risk for severe outcomes from COVID-19; however, there is no difference for angiotensin receptor blockers versus placebo for management of COVID-19, according to two studies published online Nov. 16 in The BMJ.

MONDAY, Nov. 28, 2022 (HealthDay News) -- Parents whose toddlers use certain Green Sprouts bottles or cups need to discard them immediately because of a risk for lead exposure, the U.S. Consumer Product Safety Commission (CPSC) warns. When the base of the cups comes apart, it exposes a solder dot that contains lead, according to a CPSC news release.

MONDAY, Nov. 28, 2022 (HealthDay News) -- U.S. health officials are tracking a new COVID-19 variant that is a combination of two earlier omicron subvariants. Known as XBB, this latest subvariant now represents 3.1 percent of new COVID-19 cases throughout the United States and 5 percent of cases in the Northeast.

  • Updated

MONDAY, Nov. 28, 2022 (HealthDay News) -- For children with a high prevalence of vitamin D deficiency (25-hydroxyvitamin D [25(OH)D] <20 ng/mL), vitamin D3 supplementation increases 25(OH)D concentrations but does not influence growth, body composition, or pubertal development, according to a study published online Nov. 28 in JAMA Pediatrics.

Get up-to-the-minute news sent straight to your device.


Breaking News

News Alert